JILL PRICKEL: Open Payments
NPI 1316451701 · GREENSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 22 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $169 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| PFIZER INC. | 2 | $47 |
| Novo Nordisk Inc | 2 | $32 |
| Lilly USA, LLC | 2 | $32 |
| HARMONY BIOSCIENCES LLC | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $19 |
| Radius Health, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, MOUNJARO, QULIPTA, VYNDAQEL, NURTEC ODT, WAKIX, Kerendia.
Industry payments across IN — which companies pay providers there.
